Bortezomib responsive refractory anti-N-methyl-D-aspartate receptor encephalitis
Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a central nervous system ; inflammatory autoimmune disease affecting adults and children. The use of first and second-line immunotherapies is supported. Recent reports suggest the efficacy of bortezomib in severe anti-NMDAR encephalitis in adult patients not responsive to second-line treatment, there are no data about paediatric patients.
Source: Pediatric Neurology - Category: Neurology Authors: Ramona Cordani, Concetta Micalizzi, Thea Giacomini, Matteo Gastaldi, Diego Franciotta, Francesca Fioredda, Silvia Buratti, Giovanni Morana, Daniela Pirlo, Salvatore Renna, Elio Castagnola, Marco Risso, Paola Lanteri, Maria Stella Vari, Maria Margherita Ma Tags: Short Communication Source Type: research
More News: Autoimmune Disease | Brain | Children | Encephalitis | Immunotherapy | Neurology | Pediatrics | Velcade